Literature DB >> 26360447

Secondary depression in severe anxiety disorders: a population-based cohort study in Denmark.

Sandra M Meier1, Liselotte Petersen2, Manuel Mattheisen3, Ole Mors4, Preben B Mortensen2, Thomas M Laursen2.   

Abstract

BACKGROUND: Depression and anxiety disorders are highly comorbid conditions and a worldwide disease burden; however, large-scale studies delineating their association are scarce. In this retrospective study, we aimed to assess the effect of severe anxiety disorders on the risk and course of depression.
METHODS: We did a population-based cohort study with prospectively gathered data in Denmark using data from three Danish population registers: The Danish Civil Registration System, the Danish Psychiatric Central Register, and the Danish National Hospital Registry. We selected the cohort from people born in Denmark between Jan 1, 1955, and Dec 31, 2002, who we followed up from Jan 1, 1994, to Dec 31, 2012. The cohort was restricted to individuals with known parents. First, we investigated the effect of specific anxiety diagnoses on risk of single depressive episodes and recurrent depressive disorder. Second, we investigated the effect of comorbid anxiety on risk of readmission for depression, adjusting for sex, age, calendar year, parental age, place at residence at time of birth, and the interaction of age with sex.
FINDINGS: We included 3,380,059 individuals in our study cohort. The adjusted incidence rate ratio (IRR) for single depressive episodes was 3·0 (95% CI 2·8-3·1, p<0·0001) and for recurrent depressive disorder was 5·0 (4·8-5·2) in patients with severe anxiety disorders compared with the general population. Compared with control individuals, the offspring of parents with anxiety disorders were more likely to be diagnosed with single depressive episodes (1·9, 1·8-2·0) or recurrent depressive disorder (2·1, 1·9-2·2). Comorbid anxiety increased the readmission rates in both patients with single depressive episodes and patients with recurrent depressive disorder.
INTERPRETATION: Severe anxiety constitutes a significant risk factor for depression. Focusing on specific anxiety disorders might help to identify individuals at risk of depression, thereby providing new insights for prevention and treatment. FUNDING: The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH).
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26360447      PMCID: PMC5087327          DOI: 10.1016/S2215-0366(15)00092-9

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


  43 in total

1.  Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults.

Authors:  M B Stein; M Fuetsch; N Müller; M Höfler; R Lieb; H U Wittchen
Journal:  Arch Gen Psychiatry       Date:  2001-03

2.  The four-year course of major depressive disorder: the role of staging and risk factor determination.

Authors:  Lynn Boschloo; Robert A Schoevers; Aartjan T F Beekman; Johannes H Smit; Albert M van Hemert; Brenda W J H Penninx
Journal:  Psychother Psychosom       Date:  2014-08-06       Impact factor: 17.659

3.  The Danish National Hospital Register. A valuable source of data for modern health sciences.

Authors:  T F Andersen; M Madsen; J Jørgensen; L Mellemkjoer; J H Olsen
Journal:  Dan Med Bull       Date:  1999-06

4.  The Danish Psychiatric Central Research Register.

Authors:  Ole Mors; Gurli P Perto; Preben Bo Mortensen
Journal:  Scand J Public Health       Date:  2011-07       Impact factor: 3.021

5.  A family study of obsessive-compulsive disorder.

Authors:  D L Pauls; J P Alsobrook; W Goodman; S Rasmussen; J F Leckman
Journal:  Am J Psychiatry       Date:  1995-01       Impact factor: 18.112

6.  Adolescent psychopathology: IV. Specificity of psychosocial risk factors for depression and substance abuse in older adolescents.

Authors:  P M Lewinsohn; I H Gotlib; J R Seeley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-09       Impact factor: 8.829

7.  The effects of anxiety, substance use and conduct disorders on risk of major depressive disorder.

Authors:  J M Hettema; C A Prescott; K S Kendler
Journal:  Psychol Med       Date:  2003-11       Impact factor: 7.723

8.  Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder.

Authors:  Katja Beesdo; Daniel S Pine; Roselind Lieb; Hans-Ulrich Wittchen
Journal:  Arch Gen Psychiatry       Date:  2010-01

9.  Childhood adversities and first onset of psychiatric disorders in a national sample of US adolescents.

Authors:  Katie A McLaughlin; Jennifer Greif Green; Michael J Gruber; Nancy A Sampson; Alan M Zaslavsky; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2012-11

10.  Maternal depressive symptoms and children's emotional problems: can early child care help children of depressed mothers?

Authors:  Catherine M Herba; Richard E Tremblay; Michel Boivin; Xuecheng Liu; Chantal Mongeau; Jean R Séguin; Sylvana M Côté
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

View more
  18 in total

1.  Genetic Variants Associated With Anxiety and Stress-Related Disorders: A Genome-Wide Association Study and Mouse-Model Study.

Authors:  Sandra M Meier; Kalevi Trontti; Kirstin L Purves; Thomas Damm Als; Jakob Grove; Mikaela Laine; Marianne Giørtz Pedersen; Jonas Bybjerg-Grauholm; Marie Bækved-Hansen; Ewa Sokolowska; Preben B Mortensen; David M Hougaard; Thomas Werge; Merete Nordentoft; Gerome Breen; Anders D Børglum; Thalia C Eley; Iiris Hovatta; Manuel Mattheisen; Ole Mors
Journal:  JAMA Psychiatry       Date:  2019-09-01       Impact factor: 21.596

2.  Maladaptive avoidance patterns in Parkinson's disease are exacerbated by symptoms of depression.

Authors:  Jony Sheynin; Irina Baetu; Lyndsey E Collins-Praino; Catherine E Myers; Robyn Winwood-Smith; Ahmed A Moustafa
Journal:  Behav Brain Res       Date:  2020-01-11       Impact factor: 3.332

Review 3.  Genetics of Anxiety Disorders.

Authors:  Sandra M Meier; Jürgen Deckert
Journal:  Curr Psychiatry Rep       Date:  2019-03-02       Impact factor: 5.285

4.  Increased ASL-CBF in the right amygdala predicts the first onset of depression in healthy young first-degree relatives of patients with major depression.

Authors:  Ningning Zhang; Jiasheng Qin; Jinchuan Yan; Yan Zhu; Yuhao Xu; Xiaolan Zhu; Shenghong Ju; Yuefeng Li
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-04       Impact factor: 6.200

5.  Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.

Authors:  Lucie Bartova; Markus Dold; Hans-Peter Volz; Erich Seifritz; Hans-Jürgen Möller; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-09       Impact factor: 5.270

6.  The Diagnosis and Treatment of Anxiety Disorders.

Authors:  Andreas Ströhle; Jochen Gensichen; Katharina Domschke
Journal:  Dtsch Arztebl Int       Date:  2018-09-14       Impact factor: 5.594

7.  The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.

Authors:  Jeffrey R Strawn; Jeffrey A Mills; Beau A Sauley; Jeffrey A Welge
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-02-08       Impact factor: 8.829

8.  Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark.

Authors:  Sandra M Meier; Manuel Mattheisen; Ole Mors; Diana E Schendel; Preben B Mortensen; Kerstin J Plessen
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

9.  Increased mortality among people with anxiety disorders: total population study.

Authors:  Sandra M Meier; Manuel Mattheisen; Ole Mors; Preben B Mortensen; Thomas M Laursen; Brenda W Penninx
Journal:  Br J Psychiatry       Date:  2016-07-07       Impact factor: 9.319

Review 10.  Anxiety disorders.

Authors:  Brenda Wjh Penninx; Daniel S Pine; Emily A Holmes; Andreas Reif
Journal:  Lancet       Date:  2021-02-11       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.